Australian-owned teleophthalmology and clinical communication platform Oculo will change hands in the coming months following an announcement this week that Finnish ophthalmic diagnostics company Revenio has purchased the platform. Read more
Opthea treats first patient in Phase 3 nAMD trial
The first patient in the Phase 3 clinical trial of a Melbourne-based drug company’s novel therapy for neovascular age-related macular degeneration (nAMD) has been treated in the US. Read more
EyeQ and NOC announce executive reshuffle
A new alliance between Australian optometry groups National Optical Care (NOC) and EyeQ Optometrists has sparked personnel changes involving the CEOs of both entities. Read more
Aussie-based MGD trial advances towards FDA approval
Australia’s relative success at managing COVID-19 has meant an overseas biotechnology company can forge ahead with the final phase of clinical trials before its meibomian gland dysfunction (MGD) therapy is considered by US regulators. Read more
SMILE performed on more than four million eyes
Four million eyes have now been treated globally with Zeiss Meditec’s SMILE procedure, helping cement the company’s dominance in the laser vision correction segment where it holds 27% market share. Read more
Making the independent optometrist look good
Zacharia Naumann Optometry has made its frames range a defining feature of its practice. Practice manager BERNIE ZACHARIA explains how a 15-year partnership with Eyes Right Optical has helped the business flourish in the face of increasing competition.
How optometry is bouncing back
Specsavers data has quantified the impact of extended lockdowns on Victorian eye health for the first time. DR BEN ASHBY delves into the data, and explains why metropolitan Melbourne isn’t out of the woods yet.
Major boost for optical practices with expansion of wage subsidy program
A fresh surge of optical practices are set to benefit from the Federal Government’s traineeship wage subsidy initiative after Prime Minister Scott Morrison removed a cap on the program and extended it for another 12 months.
Fair Work reaches decision on legal saga that threatened optometry salaries
The Fair Work Commission has delivered an inconclusive decision regarding pay awards coverage for optometrists. However, Optometry Australia (OA) is encouraged by the ruling after initial fears it may drive down wages, particularly for graduates whose $80,000 salaries could have dropped to as low as $53,000 per year.
Specsavers inducts 2021 graduates in new-look event
Specsavers has welcomed more than 120 graduates for 2021 in its first ever ‘hybrid-virtual’ induction event. Read more